Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Financing Activities: 2010-2013

Historic Cash from Financing Activities for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to $2.4 million.

  • Sonoma Pharmaceuticals' Cash from Financing Activities rose 1952.27% to $2.4 million in Q1 2013 from the same period last year, while for Mar 2013 it was $3.8 million, marking a year-over-year increase of 8.73%. This contributed to the annual value of $3.0 million for FY2025, which is 80.79% up from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Cash from Financing Activities of $2.4 million as of Q1 2013, which was up 529.70% from -$569,000 recorded in Q4 2012.
  • Sonoma Pharmaceuticals' 5-year Cash from Financing Activities high stood at $2.6 million for Q4 2011, and its period low was -$569,000 during Q4 2012.
  • Its 3-year average for Cash from Financing Activities is $784,000, with a median of -$132,000 in 2012.
  • Per our database at Business Quant, Sonoma Pharmaceuticals' Cash from Financing Activities tumbled by 342.86% in 2011 and then skyrocketed by 1,952.27% in 2013.
  • Quarterly analysis of 4 years shows Sonoma Pharmaceuticals' Cash from Financing Activities stood at $959,000 in 2010, then soared by 174.45% to $2.6 million in 2011, then tumbled by 121.62% to -$569,000 in 2012, then spiked by 1,952.27% to $2.4 million in 2013.
  • Its Cash from Financing Activities was $2.4 million in Q1 2013, compared to -$569,000 in Q4 2012 and -$491,000 in Q3 2012.